| Title: |
Neuropeptide 26RFa (QRFP) is a key regulator of glucose homeostasis and its activity is markedly altered in obese/hyperglycemic mice. |
| Authors: |
Prévost, Gaëtan, Arabo, Arnaud, Le Solliec, Marie-Anne, Bons, Justine, Picot, Marie, Maucotel, Julie, Berrahmoune, Hind, Mehdi, Mouna El, Cherifi, Saloua, Benani, Alexandre, Nédélec, Emmanuelle, Coëffier, Moïse, Leprince, Jérôme, Nordqvist, Anneli, Brunel, Valéry, Déchelotte, Pierre, Lefebvre, Hervé, Anouar, Youssef, Chartrel, Nicolas |
| Source: |
American Journal of Physiology: Endocrinology & Metabolism; Jul2019, Vol. 317 Issue 1, pE147-E157, 11p |
| Abstract: |
Recent studies have shown that the hypothalamic neuropeptide 26RFa regulates glucose homeostasis by acting as an incretin and increasing insulin sensitivity. In this study, we further characterized the role of the 26RFa/GPR103 peptidergic system in the global regulation of glucose homeostasis using a 26RFa receptor antagonist and also assessed whether a dysfunction of the 26RFa/ GPR103 system occurs in obese hyperglycemic mice. First, we demonstrate that administration of the GPR103 antagonist reduces the global glucose-induced incretin effect and insulin sensitivity whereas, conversely, administration of exogenous 26RFa attenuates glucoseinduced hyperglycemia. Using a mouse model of high-fat diet-induced obesity and hyperglycemia, we found a loss of the antihyperglcemic effect and insulinotropic activity of 26RFa, accompanied with a marked reduction of its insulin-sensitive effect. Interestingly, this resistance to 26RFa is associated with a downregulation of the 26RFa receptor in the pancreatic islets, and insulin target tissues. Finally, we observed that the production and release kinetics of 26RFa after an oral glucose challenge is profoundly altered in the high-fat mice. Altogether, the present findings support the view that 26RFa is a key regulator of glucose homeostasis whose activity is markedly altered under obese/hyperglycemic conditions. [ABSTRACT FROM AUTHOR] |
|
Copyright of American Journal of Physiology: Endocrinology & Metabolism is the property of American Physiological Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
